Deal Library / Pharma BD Deal Intelligence

Sanofi-Aventis — Pharma Deals

The Pharma Closeout tracks 7 deals, $6.9B in disclosed deal value, 6 with a post-close Outcome Score for Sanofi-Aventis.

Median Critic Score: 75 · Median Outcome Score: 35

All 7 deals

Sanofi-Aventis / Symbion Consumer (Primary Health Care) — 2008 · $544M · Largely worked — most objectives met.
Sanofi-Aventis / Merial Limited (Merck's 50% interest) — 2009 · $4.0B · Largely worked — most objectives met.
Sanofi-Aventis / Acambis plc — 2008 · $548M · Underwhelmed — fell short of the thesis.
Sanofi-Aventis / Shantha Biotechnics Limited — 2009 · $784M · Underwhelmed — fell short of the thesis.
Sanofi-Aventis / Fovea Pharmaceuticals SA — 2009 · $541M · Did not work — the deal failed to deliver.
Sanofi-Aventis / BiPar Sciences, Inc. — 2009 · $500M · Did not work — the deal failed to deliver.
Sanofi-Aventis / ImmunoGen Inc. — 2005 · $18M